Division of Infectious Diseases, The Children's Hospital of Philadelphia and the Departments of Pediatrics and Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
J Hosp Med. 2011 May;6(5):256-63. doi: 10.1002/jhm.872. Epub 2011 Mar 3.
To determine the comparative effectiveness of common pleural drainage procedures for treatment of pneumonia complicated by parapneumonic effusion (ie, complicated pneumonia).
Multicenter retrospective cohort study.
Forty children's hospitals contributing data to the Pediatric Health Information System.
Children with complicated pneumonia requiring pleural drainage.
Initial drainage procedures were categorized as chest tube without fibrinolysis, chest tube with fibrinolysis, video-assisted thoracoscopic surgery (VATS), and thoracotomy.
Length of stay (LOS), additional drainage procedures, readmission within 14 days of discharge, and hospital costs.
Initial procedures among 3500 patients included chest tube without fibrinolysis (n = 1762), chest tube with fibrinolysis (n = 623), VATS (n = 408), and thoracotomy (n = 797). Median age was 4.1 years. Overall, 716 (20.5%) patients received an additional drainage procedure (range, 6.8-44.8% across individual hospitals). The median LOS was 10 days (range, 7-14 days across individual hospitals). The median readmission rate was 3.8% (range, 0.8%-33.3%). In multivariable analysis, differences in LOS by initial procedure type were not significant. Patients undergoing initial chest tube placement with or without fibrinolysis were more likely to require additional drainage procedures. However, initial chest tube without fibrinolysis was the least costly strategy.
There is variability in the treatment and outcomes of children with complicated pneumonia. Outcomes were similar in patients undergoing initial chest tube placement with or without fibrinolysis. Those undergoing VATS received fewer additional drainage procedures but had no differences in LOS compared with other strategies.
比较治疗肺炎合并脓胸(即合并性肺炎)的常见胸腔引流程序的疗效。
多中心回顾性队列研究。
向儿科健康信息系统提供数据的 40 家儿童医院。
需要胸腔引流的合并性肺炎患儿。
初始引流程序分为无纤溶酶原胸腔引流管、有纤溶酶原胸腔引流管、电视辅助胸腔镜手术(VATS)和开胸手术。
住院时间(LOS)、额外引流程序、出院后 14 天内再入院和住院费用。
3500 例患者的初始程序包括无纤溶酶原胸腔引流管(n = 1762)、有纤溶酶原胸腔引流管(n = 623)、VATS(n = 408)和开胸手术(n = 797)。中位年龄为 4.1 岁。总体而言,716 例(20.5%)患者接受了额外的引流程序(范围为各医院 6.8%-44.8%)。中位 LOS 为 10 天(范围为各医院 7-14 天)。中位再入院率为 3.8%(范围为 0.8%-33.3%)。多变量分析显示,初始程序类型对 LOS 的差异无统计学意义。接受初始胸腔引流管置管加或不加纤溶酶原的患者更有可能需要额外的引流程序。然而,初始无纤溶酶原胸腔引流管是最具成本效益的策略。
儿童合并性肺炎的治疗和结局存在差异。接受初始胸腔引流管置管加或不加纤溶酶原的患者的结局相似。与其他策略相比,接受 VATS 的患者接受的额外引流程序较少,但 LOS 无差异。